SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HIV-VAC, Inc. (HIVC) Leading the world to a cure
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Blue-Horseshoe who wrote (5)5/21/1999 6:39:00 PM
From: fmrick  Read Replies (1) of 76
 
Don't you think you are jumping the gun a little?

Phase I- 1 to 2 years (application, approval, trial, results published)

Phase II- 1 to 2 years (same)

Phase III- 3-5 years (same, but must prove it works)

The other companies working on AIDS vaccines are years ahead. All of them say a phase III alone will take 3-5 years. The reason for the length is it takes that long for the virus to develop in some people. Therefore you cannot say a vaccine worked until you know your test subjects did not develop the virus, and that takes years.

FDA fast track only assures the final approval process will be faster.
Rick

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News